CD8A and cancer: Lactic acid mediates the release of EV from cancer cells, which in turn inhibits various immune cytotoxicity such as CD8 T cells and NK cells as well as DC-mediated antigen presentation, and enhances the immunosuppressive function of Tregs and MDSCs, thereby promoting the immune escape of cancer cells.